Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 19.47 is in line with its 5-year average of 17.96, around the middle of its 5-year range (3.70–37.98).
As of the fiscal period ended Tuesday, June 30, 2026. 0.23% above its 12-month average of 19.42.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.47.
CURRENT RATIO
19.47
CURRENT RATIO AVG TTM
19.42
CURRENT RATIO AVG 3Y
14.71
CURRENT RATIO AVG 5Y
17.96
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.23%
CURRENT VS 3Y AVG
+32.34%
CURRENT VS 5Y AVG
+8.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+419.13%
vs the sector median at left
Immuneering Corporation
Market Cap
$139.95M
Current Ratio
19.47
TTM Avg
19.42
3Y Avg
14.71
5Y Avg
17.96
Market Cap
$138.03M
Current Ratio
2.72
TTM Avg
2.55
3Y Avg
3.48
5Y Avg
5.33
Market Cap
$144.06M
Current Ratio
3.96
TTM Avg
1.88
3Y Avg
1.73
5Y Avg
2.58
Market Cap
$135.82M
Current Ratio
8.73
TTM Avg
6.53
3Y Avg
6.53
5Y Avg
6.53
Market Cap
$145.33M
Current Ratio
10.97
TTM Avg
15.14
3Y Avg
14.12
5Y Avg
22.71
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immuneering Corporation (IMRX) | $139.95M | 19.47 | 19.42 | 14.71 | 17.96 |
| Sutro Biopharma, Inc. (STRO)vs › | $139.93M | 3.32 | 2.30 | 3.60 | 5.41 |
| Alpha Cognition Inc (ACOG)vs › | $138.54M | 9.03 | 11.82 | 6.24 | 5.64 |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.03M | 2.72 | 2.55 | 3.48 | 5.33 |
| Nyxoah S.A. (NYXH)vs › | $142.60M | 2.38 | 2.90 | 4.31 | 7.34 |
| Organigram Global Inc. (OGI)vs › | $136.58M | 2.61 | 3.59 | 4.71 | 5.61 |
| Fortress Biotech, Inc. (FBIOP)vs › | $144.06M | 3.96 | 1.88 | 1.73 | 2.58 |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.82M | 8.73 | 6.53 | 6.53 | 6.53 |
| Protara Therapeutics, Inc. (TARA)vs › | $145.33M | 10.97 | 15.14 | 14.12 | 22.71 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $145.89M | 1.23 | 1.14 | 1.35 | 4.96 |
Current Ratio
19.47
Quick Ratio
19.47
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 19.47 |
| 2026-03-31 | 32.45 |
| 2025-12-31 | 17.50 |
| 2025-09-30 | 24.00 |
| 2025-06-30 | 3.70 |
| 2025-03-31 | 7.48 |
| 2024-12-31 | 5.28 |
| 2024-09-30 | 7.99 |
| 2024-06-30 | 9.39 |
| 2024-03-31 | 14.38 |
| 2023-12-31 | 11.35 |
| 2023-09-30 | 17.89 |
| 2023-06-30 | 20.35 |
| 2023-03-31 | 17.05 |
| 2022-12-31 | 13.50 |
| 2022-09-30 | 16.54 |
| 2022-06-30 | 33.99 |
| 2022-03-31 | 37.98 |
| 2021-12-31 | 27.04 |
| 2021-09-30 | 29.11 |
| 2021-06-30 | 10.65 |
| 2021-03-31 | 11.67 |
| 2020-12-31 | 16.73 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
